Tests lemborexant for sleep problems in people with epilepsy
Tests whether lemborexant improves sleep in adults with epilepsy.
Plain-language title generated from the registry record
Registry title: Lemborexant Treatment of Insomnia Linked to Epilepsy
Key facts
- Where
- Winnipeg, CanadaSee the site
- Phase
- Phase 3
Where in Canada
- Health Sciences CentreWinnipeg, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Manitoba
- Trial code
- NCT06262594
- Record updated
- 13 February 2025
- Original description
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.Read full original descriptionShow less
Lemborexant Treatment of Insomnia Linked to Epilepsy
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
Inclusion: Sleep-related focal epilepsy; Contraception.
Exclusion: Changes in antiseizure medication 1 month before study protocol or during study protocol; Concomitant medications per SUNRISE1; Individuals with hepatic impairment; Individuals with a history of complex sleep-related behaviour; Individuals with a history of dependence or tolerance - abuse, dependence, rebound insomnia; Individuals with psychiatric disorders with abnormal thinking and behavioural changes, depression, or suicidal ideation; Individuals with rare hereditary diseases of galactose intolerance such as galactosemia or glucose-galactose malabsorption; Female participants who are pregnant or breastfeeding; Individuals with compromised respiratory function; Individuals with a diagnosis of narcolepsy.